aod9604 fda approval status AOD-9604 5mg (Spray) – Modified Aminos AOD-9604 5MG - Oneday Compounds
Description
Note on humans: These benefits are not established in humans no completed clinical trials exist [1]

There is supporting evidence reporting adverse effects from long-term rhIGF-1 treatment including neoplastic formation, cataract and renal hypertrophy, all of which seem to be the most severe effects observed and are usually rare [123, 282284]

This compounded product should only be used for an approved medical purpose under close medical supervision, with follow-up lab testing as directed.
And some products on the market test far below 85% purity

Tirzepatide is sold as Zepbound for chronic weight management and as Mounjaro for type 2 diabetes, working as a dual GLP-1/GIP receptor agonist that targets both the GLP-1 and GIP receptors instead of GLP-1 alone, which enhances fat metabolism and insulin sensitivity beyond a single-receptor peptide

If you've been through diet after diet without results, Lipo-B12 injections can help
